AbbVie Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (82)

Latest Posts

About This Stock More About This Stock
Biotechs Running Again: Life Science Stocks
Article By: Rod Raynovich
Tuesday, April 25, 2017 11:59 PM EDT
Biotechs are running again taking the cue from Nasdaq which is up 3.44% in April after a brief mid-month sell-off. Biotech stocks rallied from global macro concerns which has dampened investor enthusiasm over the past two months.
In this article: BMY, FBIOX, IBB, QQQ, AMGN, GILD, XBI, XLV, ABBV, BLUE, FMI Also: RHHBY, BIIB
Read
3 Real-World Case Studies: How Spinoffs Unlock Shareholder Value
Article By: SureDividend
Tuesday, April 25, 2017 5:23 PM EDT
Will analyze three notable dividend stock spinoffs within the past decade that have successfully unlocked shareholder value.
In this article: PM, ABBV, ADNT
Read
Breaking Down The Two-Stage Dividend Discount Model For Beginners
Article By: Dave Ahern
Monday, April 24, 2017 4:31 PM EDT
Dividends are the best friend an investor has. They are the gift that keeps on giving and finding a company that pays them consistently over an extended period of time is a great way to build your wealth.
In this article: PG, ABBV Also: IBM, KO, WFC, KHC
Read
AbbVie/Enanta Post Stellar Phase 3 Data But No One Is Cheering
Article By: Lorimer Wilson
Friday, April 21, 2017 2:54 AM EDT
AbbVie Inc. and its partner Enanta Pharmaceuticals, Inc. received exceedingly good news about new Phase III data but since these drugs first went into combo clinical trials, the market has peaked and begun a painful retreat.
In this article: ABBV, ENTA Also: MRK, GILD
Read
HH Better Big Pharma Dividend Stock: AbbVie Or Gilead?
Article By: SureDividend
Tuesday, April 18, 2017 12:04 PM EDT
Gilead could provide stronger returns than AbbVie, if the company can stabilize earnings and return to growth. The stock is extremely cheap based on valuation.
In this article: GILD, ABBV Also: ABT
Read

PARTNER HEADLINES

Latest Tweets for $ABBV

No tweets yet!

$ABBV

AbbVie Inc. Increases Humira Prices, Receives FDA Approval For New Drug
Bruce Powers 1/23/2017 6:21:09 PM

Excited to hear the #FDA approved #IMBRUVICA. Should bode very well for $ABBV. And I think it's 8% price hike of #Humira is reasonable (though I realize those taking the drug may disagree).

1 to 1 of 1 comments